PARP Inhibitors
PARP Inhibitors are targeted therapies used to exploit weaknesses in cancer cells that result from defects in genes involved in DNA repair. They are particularly effective in metastatic castration-resistant prostate cancer.
PARP Inhibitors are targeted therapies used to exploit weaknesses in cancer cells that result from defects in genes involved in DNA repair. They are particularly effective in metastatic castration-resistant prostate cancer.